Isolation of Cokeromyces recurvatus, initially misidentified as Coccidioides immitis, from peritoneal fluid in a cat with jejunal perforation.

Cokeromyces recurvatus, a zygomycete, was isolated by fungal culture from the peritoneal fluid of a cat with jejunal perforation secondary to intestinal lymphosarcoma. This organism has not been recovered previously from a veterinary patient. The tissue form of C. recurvatus is morphologically similar to those of Coccidioides immitis and Paracoccidioides brasiliensis and may be misdiagnosed as 1 of these organisms on the basis of cytologic or histopathologic specimens, particularly in geographic regions where these organisms are not endemic.     

Steady-state plasma concentrations of itraconazole after oral administration in Kemp's ridley sea turtles, Lepidochelys kempi.

Pharmacokinetic studies of antifungal agents in reptiles are uncommon. Itraconazole, which has been used prophylactically in juvenile sea turtles suffering from hypothermia (cold stunning) on a regular basis, was evaluated for steady-state plasma concentrations. Five Kemp's ridley sea turtles (Lepidochelys kempi) receiving itraconazole at several dosages in a rehabilitation program had blood collected within 24 hr to estimate dosing frequency. Subsequently, serial blood samples of Kemp's ridley sea turtles that were given itraconazole at several dosages for 30 days to treat cold stunning were collected at various intervals to evaluate itraconazole plasma concentrations. Tissue samples were collected from one Kemp's ridley that died during rehabilitation. Plasma concentrations of itraconazole (and of hydroxyitraconazole [OH-ITRA], one of its major bioactive metabolites) were determined using a modified, validated reverse-phase high-performance liquid chromatography technique. Itraconazole concentrations in tissues were determined by bioassay to be far greater than the plasma concentrations measured in any of the turtles. At a 15-mg/kg dosage, the half-life (t1/2) was 75 hr for itraconazole and 55 hr for OH-ITRA. All dosages produced adequate concentrations in some turtles, but consistent therapeutic concentrations were produced only at 15 mg/kg q72hr and 5 mg/kg s.i.d., with the latter producing the highest plasma concentrations.     

Administration of certain sedative drugs is associated with variation in sonographic and radiographic splenic size in healthy cats

Ultrasonography and radiography are standard diagnostic tests for cats with suspected splenic disease, however published information on outside sources of variation are currently lacking. The purpose of this prospective, randomized, crossover group study was to evaluate effects of common sedative drugs on the sonographic and radiographic characteristics of the spleen in healthy cats. Fifteen healthy adult research cats were randomly assigned into one of three groups corresponding to different sequences of administration of five sedative drugs/drug combinations (acepromazine; butorphanol; dexmedetomidine; midazolam and butorphanol (MB); and dexmedetomidine, butorphanol, and ketamine (DBK)), administered at 1‐week intervals. At each visit, three‐view abdominal radiographic and ultrasonographic examinations were performed prior to sedation and repeated 15‐30 min and 2‐3 h post sedation. Two board‐certified radiologists (one ACVR and one ACVR/ECVDI) evaluated the anonymized and randomized images. Acepromazine resulted in significantly increased sonographic and radiographic splenic measurements from baseline, which remained significantly increased 2‐3 h post sedation. The mean magnitude of this change ranged from 0.9 mm (tail height, SD 1.4 mm) to 1.8 mm (body height, SD 1.7 mm) for ultrasound, and was 2.2 mm (ventrodorsal width, SD 2.3 mm) for radiographs. With butorphanol, there was no significant change in splenic size. For dexmedetomidine, MB, and DBK, there was a trend toward increased splenic size from baseline to the first post‐sedation timepoint, which was statistically significant for radiographic measurements, although not for ultrasound. Findings indicated that acepromazine should be avoided prior to imaging while butorphanol may be used when sedation is needed in cats presenting for potential splenic disease.     

Postamputation Orthopedic Surgery in Canine Amputees: Owner Satisfaction and Outcome

Surgical management of postamputation orthopedic disease (PAOD) in canine amputees has rarely been documented, and no reports describing outcome of stifle surgery in canine amputees are available. The objective of this multisite retrospective case series was to describe cases and evaluate satisfaction with and outcome of postamputation orthopedic surgery in canine amputees. Data was obtained through medical records and owner survey responses; data included signalment, amputation cause, diagnosis, surgical treatment, timeframes, and outcome assessment. Outcome was categorized as acceptable or unacceptable, and complications were classified as catastrophic, major, or minor. Eleven thoracic limb amputees and 6 pelvic limb amputees with surgically treated PAOD were identified. Surgically treated PAOD was reported at a median of 9.7 months (range 0.5-110 months) after amputation. All 17 amputees were treated for pelvic limb disease, predominantly for cranial cruciate ligament disease that occurred in 11 of 17 dogs. Major complications following orthopedic surgeries performed in 3 thoracic limb amputees consisted of infection (n?=?2) and uncontrolled pain (n?=?1). No major complications were reported following orthopedic surgeries performed in pelvic limb amputees. Acceptable mid-to-long-term outcome was achieved in 16 of the 17 canine amputees. Surgical treatment of pelvic limb disease did not appear to be associated with a high number of major complications in this case series. These findings suggest that orthopedic surgery, specifically stifle surgery, in canine amputees might be considered a feasible treatment option. Although there are inherent methodological limitations of retrospective studies and owner surveys, our case series provides new information that might help guide surgical treatment decisions in canine amputees suffering from orthopedic disease. Prospective studies using objective outcome measures evaluating surgical management of PAOD are necessary to confirm the provided information.     

Baylisascaris procyonis in raccoons (Procyon lotor) from eastern Colorado, an area of undefined prevalence

Baylisascaris procyonis is a zoonotic parasite that has been documented in raccoons throughout much of the United States; however, no published information on its occurrence is available for the transition zone from the Great Plains to the Rocky Mountains. Because this parasite can cause neural larva migrans and diffuse unilateral subacute neuroretinitis in humans (as well as other hosts), a more complete understanding of the distribution of this parasite seems warranted for public health reasons. The purpose of this study was to begin to fill in the gaps in our knowledge of the distribution of B. procyonis in an area of the US where there is, currently, no published information available. Fifty-three raccoons were collected throughout eastern Colorado during 2007-2010. Forty-six were examined by necropsy and seven by fecal flotation. Age (11 juveniles, 25 adults) and sex (16 males, 19 females) of the raccoons were recorded when intact carcasses were available. When available, feces were further processed for the detection of Giardia and Cryptosporidium using a direct fluorescent antibody detection method. B. procyonis was found in 31 of 53 raccoons (58.5%, 95% CI=44.1%, 71.9%). Mean intensity was 11.7 with a range of 1-49 worms per infected individual. There was no significant difference between age or sex, and the presence of ascarids or the number of ascarids. Cryptosporidium spp. oocysts and Giardia spp. cysts were detected in 11/44 (25%; 95% CI: 13.2, 40.3) and 3/44 (6.9%; 95% CI: 1.4, 18.7) raccoons, respectively. The genotype of the Giardia present could not be determined. The genotype of five of six cryptosporidial isolates was 100% homologous to the skunk genotype while the sixth was 100% homologous to Cryptosporidium parvum. Based on these results, both B. procyonis and Cryptosporidium spp. appear to be prevalent in raccoons of eastern Colorado.     

Response of sorghum stalk pathogens to <Emphasis Type="Italic">brown midrib</Emphasis> plants and soluble phenolic extracts from near isogenic lines

Sorghum [Sorghum bicolor (L.) Moench] has drawn attention as potential feedstock for lignocellulosic biofuels production, and reducing lignin is one way to increase conversion efficiency. Little research has been previously conducted to assess the response of reduced lignin sorghum lines to the Fusarium stalk rot pathogens Fusarium verticillioides and Fusarium proliferatum and the charcoal rot pathogen, Macrophomina phaseolina. Loss of function mutations in either the Brown midrib (Bmr) 6 or 12 gene that both encode a monolignol biosynthetic enzyme in the pathway that produces subunits of the lignin polymer, results in reduced lignin content. Near-isogenic bmr6, bmr12, and bmr6 bmr12 lines had previously been developed, which were shown to have significantly reduced lignin content and increased levels of soluble phenolics. In the current study, these lines in two backgrounds were shown to not be more susceptible to F. verticillioides, F. proliferatum and M. phaseolina inoculations, and some bmr lines exhibited increased resistance to F. proliferatum and M. phaseolina, compared to wild-type lines. When the Fusarium stalk rot pathogen, Fusarium thapsinum, was grown on methanol soluble stalk extracts from bmr6 and wild-type plants, it grew significantly faster on medium with bmr6 extract than on wild-type extract or controls. This result suggested that factors other than soluble phenolics from the extract, such as cell wall bound phenolics or inducible defense compounds, contributed to increased resistance observed in bmr6 plants.